Insys Therapeutics, Inc. News - INSY

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

INSYS Therapeutics Implements Leadership Changes

PHOENIX, April 15, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...

Report: Exploring Fundamental Drivers Behind Zscaler, Golden Star Resources, Flexion Therapeutics, SP Plus, Insys Therapeutic...

NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its...

INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Dru...

PHOENIX, March 25, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...

Annual Report (10-k)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...

INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results

PHOENIX, March 07, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7

PHOENIX, March 06, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G ...

INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment o...

PHOENIX, Feb. 25, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Insys Therapeutics, Inc. (INSY)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

INSY News

Current Report Filing (8-k)

INSYS Therapeutics Implements Leadership Changes

Report: Exploring Fundamental Drivers Behind Zscaler, Golden Star Resources, Flexion Therapeutics, SP Plus, Insys Therapeutic...

INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Dru...

Annual Report (10-k)

Current Report Filing (8-k)

INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results

Amended Statement of Ownership (sc 13g/a)

INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7

Amended Statement of Ownership (sc 13g/a)

INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment o...

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis

INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference

INSY Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Insys Therapeutics, Inc. (INSY) News

Insys Therapeutics, Inc. (INSY)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

INSY News

Current Report Filing (8-k)

INSYS Therapeutics Implements Leadership Changes

Report: Exploring Fundamental Drivers Behind Zscaler, Golden Star Resources, Flexion Therapeutics, SP Plus, Insys Therapeutic...

INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Dru...

Annual Report (10-k)

Current Report Filing (8-k)

INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results

Amended Statement of Ownership (sc 13g/a)

INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7

Amended Statement of Ownership (sc 13g/a)

INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment o...

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis

INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference

INSY Discussion

Your Recent History